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ABSTRACT 
Background Over 150,000 suspected TIAs are referred to outpatient clinics in England each 
year, the majority by GPs. 
Aim To identify how many patients referred to TIA clinic actually have TIA (i.e. calculate the 
positive predictive value of first-contact healthcare referral) and to record the alternative 
diagnoses in patients without TIA. 
Design and setting Systematic review. TIA clinic referrals from first-contact healthcare (GPs 
and Emergency Department doctors). 
Method Four databases were searched using terms for TIA and diagnostic accuracy. Data on 
the number of patients referred to TIA clinic that actually had a TIA (positive predictive 
values) were extracted. Frequencies of differential diagnoses were recorded, where 
reported. Study quality was assessed using the QUADAS-2 tool.  
Results Nineteen studies were included and reported sufficient information on referrals 
from GPs and EDs to derive positive predictive values (PPVs) (n=19,640 referrals). PPVs for 
TIA ranged from 12.9 to 72.5%.  A formal meta-analysis was not conducted due to 
heterogeneity across studies. In those not diagnosed with TIA, about half of the final 
diagnoses were neurological or cardiovascular conditions. 
Conclusion This study highlights the variation in prevalence of true vascular events in 
patients referred to TIA clinics. For patients without a cerebrovascular diagnosis, the high 
prevalence of conditions that also require specialist investigations and management are an 
additional burden on a care pathway that is primarily designed for prevention of recurrent 
stroke. Commissioners of services need to assess if the existing outpatient provision is 
optimal for people with pathologies other than cerebrovascular disease. 
Keywords ischemic attack, transient; stroke; diagnosis; predictive value of tests; primary 
health care; general practitioners 
 
How this fits in  
The PPV of a TIA clinic referral has previously been described in selected populations in 
single studies. We conducted a systematic review and found that 12.9 to 72.5% of clinic 
referrals had a confirmed TIA and was usually above 50% when a composite (TIA or minor 
stroke) reference standard was used. Alternate diagnoses suggest that the total population 
with transient neurological symptoms may represent a susceptible population for further 
investigations and treatment which is not presently discussed in UK Stroke and TIA 
guidance. Commissioners should ensure that TIA services can meet the needs of a 
heterogenous patient group. 
 
INTRODUCTION 
A transient ischaemic attack (TIA) is a temporary focal neurological disturbance due to an 
interruption in the blood supply to an area of the brain. (1) We use the term transient 
neurological symptoms to describe the broad range of symptoms that may occur following a 
TIA or another condition that may mimic TIA. There is no ‘gold standard’ clinical test that 
can be used to diagnose a TIA or stroke based on symptomology. The diagnosis of TIA is 
based on the assessment of symptoms and ‘adequate’ investigation by a clinician. 
Historically TIA symptoms would need to resolve within 24 hours to be classified as TIA and 
not a minor stroke; however, in 2009 a tissue-based definition of TIA was proposed: 
‘Transient ischemic attack (TIA): a transient episode of neurological dysfunction caused by 
focal brain, spinal cord, or retinal ischemia, without acute infarction’. (1, 2) In practice 
however, the time-based definition may be the more operable, working definition, because 
identification of infarcts requires imaging and not all TIA clinic attendees are imaged. 
 
The incidence of transient neurological symptoms is high, estimated at 190 cases per 
100,000 population (3)and clinic referral rates in the order of about 16 per 10,000 patients 
every year. (4) Outpatient TIA clinics are well equipped to identify and treat TIA and minor 
stroke, but only a proportion of suspected TIA cases will be confirmed.  Those not 
presenting with a TIA may nevertheless suffer adverse health consequences. (5) The clinical 
assessment for TIA can be complex as the symptoms are transient and there are no 
persisting signs on examination to guide the referring clinician.  There has been one 
previous brief review of predictive values in TIA, but an update is timely as there has been 
more published data to inform estimates of accuracy as well as richer data on alternative 
diagnoses in this complex clinic population. (6) The objective of our study was to evaluate 
the positive predictive values associated with first-contact healthcare referral, i.e. from 
General Practice (GP) or from an Emergency Department (ED), to TIA clinic and to describe 
the alternative diagnoses in referred patients. 
 
METHODS 
Data sources  
Four databases (MEDLINE, EMBASE, and The Cochrane Database of Systematic Reviews and 
Database of Reviews and Effectiveness) were searched from 1989 to week 28, 2016 using 
terms for “TIA” combined with a diagnostic filter (supplementary file A1). We used the 
Bachmann filter (adapted to run on each database) which has been identified as one of the 
most sensitive diagnostic filters available, with acceptable precision (7). Additional papers 
were sought by screening the citations of retrieved studies. All data screening, extraction 
and full text assessment was done by a single reviewer and checked in detail by a second. 
 
 
Inclusion criteria  
Primary studies of any design, conference abstracts and systematic reviews reporting 
information necessary to derive positive predictive values of TIA diagnosis from first-contact 
healthcare (primarily GPs or ED doctors). Where more than one study reported the same 
predictive values, duplicate values were not reported. Where there was a duplication of 
reporting, preference was given to full-text studies which report the most detail with 
respect to the application of the index test and reference standard. 
 
Data Extraction and Quality Assessment of Studies 
Data were extracted on the type of study, geographic location, method for patient selection, 
age of the population and number of patients included in the study. We collected 
information on the positive and negative diagnoses, along with frequencies of unverified 
diagnoses, which reference standard the study applied (TIA alone or TIA and minor stroke), 
and what definition of TIA was used (tissue or time-based). Systematic reviews were 
identified as a source or relevant studies. QUADAS-2 was used to assess the risk of bias and 
applicability of included studies (8). We also recorded the frequencies of differential 
diagnoses for false positive TIAs. The details of all non TIA/stroke diagnoses were tabulated.  
 
Statistical analysis and synthesis 
For each study we calculated the PPV as number of true positives divided by the sum of true 
and false positives (i.e. the total number of patients referred to the clinic).  The binomial 
exact standard errors were calculated where the standard error of the PPV was not 
reported.  Due to high unexplained variation in the underlying prevalence of TIA, we chose 
not to estimate summary PPV.   Forest plots were used to display the individual study 
estimates of PPV together with 95% CIs analysing the target conditions (TIA and the 
composite outcome of TIA and minor stroke) separately. While our main analysis reports 
results for full texts only, we carried out a sensitivity analysis including conference abstracts 
to examine the robustness of our results.  
 
 
RESULTS 
The search identified 3,924 unique records. Of these, 19 full texts met the eligibility criteria 
(Figure 1). Twelve conference abstracts also met inclusion criteria; these were included in 
the sensitivity analysis. Study characteristics are presented in Table A2. 
 
Figure 1 
 
Nine studies were conducted in the UK, three in Ireland, three in Australia, two in Portugal 
and one in each of Spain and France. All patients identified were TIA clinic 
referrals/attendees, using consecutive or all referrals within a given timeframe. 19 studies 
provided sufficient information to calculate the PPV for at least one of the reference 
diagnoses (TIA and or the composite reference diagnosis of TIA and minor stroke). The 
number of suspected TIAs referred from or including GPs (18/19 studies included this route) 
ranged from 52 to 3533 clinic attendees (Table A2). (9, 10) 
 
Specialist diagnosis (reference standard) 
In all cases, the reference standard was the clinical diagnosis of the stroke physician in clinic. 
Several studies reported that the assessment of TIA was standardised at their clinic, and/or 
of additional retrospective notes review to confirm the diagnosis made by a senior 
stroke/vascular specialist. Studies dichotomised diagnoses into two outcomes (TIA, which 
sometimes included minor stroke) and not TIA. All studies with the exception of a 
conference abstract included in the sensitivity analysis (11) where the tissue-based 
definition was used, used the time-based definition of TIA even where the later tissue-based 
definition was available. 
 
Differential diagnoses  
Twelve of the included studies reported on the final diagnoses received by patients, 
although one study did not report sufficient information to determine frequencies for all 
alternate diagnoses. (12) Where reported, the frequency of alternative diagnoses are shown 
in Table A3.  
The range of conditions diagnosed includes diseases which have NICE guidance 
recommending assessment by an appropriately trained specialist such as multiple sclerosis, 
epilepsy and cardiac arrhythmias. The commonest diagnoses were seizure, syncope, 
transient global amnesia, tension headache and migraine (Table A3). 
 
Unexplained diagnoses 
The majority of studies did not provide clear information on the number of patients for 
whom there was no clear diagnosis following referral to a TIA clinic. (Table A3). Several 
studies had a “possible TIA” category (13, 14) with symptoms which were broadly consistent 
with, but not clearly diagnostic for TIA; and “non-TIA” when this was not the case. Since the 
diagnosis was essentially unconfirmed in these cases, our analysis treats possible TIA as 
essentially unexplained i.e. negative cases in our analysis of PPV. 
 
 
Positive predictive values of TIA from first-contact healthcare 
The proportion of referred patients with a final diagnosis of TIA and/or minor stroke ranged 
from 22.0 to 77.9% (figure 2), and ranged from 12.9 to 68.6% of patients with a final 
diagnosis of TIA (figure 3).  However, the distribution of PPV estimates appear to differ 
depending on the reference standard as 13/18  studies have a PPV ≥ 50% for a combined TIA 
and minor stroke outcome but only 4/18 studies have a PPV ≥ 50% when the reference 
standard was just TIA.  
 
Assessment of study quality 
Application of the QUADAS-2 checklist yielded similar results across studies, with all studies 
having a high risk of bias in the reference standard domain. The bias relates to the absence 
of a “gold standard” test and that the diagnostician knows that the patients were referred 
as suspected TIA (as all patients were seen in routine TIA clinics). 
 
Influence of referral source and referral criterion 
The majority of studies included all referrals and did not report on the composition of 
referrals (GP or ED) and/or provide sufficient data to calculate PPVs by referral source. It is 
plausible that studies may have included referrals from other sources such as 
ophthalmology, and secondary care, but reporting on this issue was scant. Two studies (9, 
15) provided sufficient information to calculate PPVs according to two referral routes (GP or 
ED) and a further study provided this information on PPVs for referrals purely from GPs (16). 
A further study gave PPVs predominantly from an ED setting (17), whereas all other studies 
appear to have largely comprised referred from GPs. With the exception of one small study 
(9), the PPVs appear lower in GP referrals than in referrals from ED. Only one study which 
restricted itself to suspected anterior circulation TIA events (18), described specific referral 
criteria. 
 
Figure 2, Figure 3 
 
Impact of including conference abstracts 
In general, interpretation of the results did not change when conference abstracts were 
included (figure A4, A5), however, Kleinig et al. (11) had much lower PPVs for both TIA (7.1% 
CI: 3.9-11.6) and the combined outcome (16.7 CI: 11.7-22.6). This study was set in an MRI-
based referral clinic using the tissue-based reference standard. 
 
Discussion 
Summary of key findings:  
Our review has identified considerable variability in PPVs for TIA across studies. The subset 
of studies we identified which report on alternative diagnoses highlights the predominance 
of additional neurological and cardiological diseases which are TIA mimics requiring 
specialist assessment either within the TIA service or at a subsequent specialty clinic 
attendance. While our review demonstrates a variation in PPVs across studies, it could be 
that this is explained by a combination of referral source and diagnostic criteria, study age 
and/or the cardiovascular event being diagnosed. For instance, we found some evidence to 
suggest that PPVs in Primary Care populations may be lower than in those which included 
ED. However, inference about the possible influence of referral source and referral criterion 
is difficult because of other study differences. PPVs also tended to be higher in studies 
conducted in recent years, which might reflect a change in operation of the diagnostic 
criteria and improving recognition of symptoms by doctors over time. Finally, studies which 
included stroke had higher PPVs; this might reflect the broader diagnostic criteria or that 
GPs and ED doctors may be more likely to correctly identify a stroke due to the persistent 
nature of the deficit. 
 
Strengths and limitations: Since there was no assessment of patients not thought by first-
contact health care to have suffered a TIA, we do not know how many people with TIAs 
were missed. Therefore, we cannot compute sensitivity or specificity. This means that we 
cannot interpret whether high predictive values were associated with higher referral 
thresholds (which is likely to be associated with lower sensitivity, i.e. more TIAs missed by 
first-contact health care). It also means that we cannot compute prevalence of TIA in the 
population seen by first-contact health care, which is a key determinant of predictive value.  
 
While we think the reference standard is acceptable – in all cases it was analogous to how 
diagnoses are made in practice – specialists were not blind to the index GP/ED diagnosis. 
This might foreseeably lead to more non-TIAs being misclassified as TIAs. 
 
To explore potential publication bias, we included conference abstracts in a sensitivity 
analysis. Predictive values for TIA were similar, suggesting that publication bias is unlikely to 
be a major issue. 
 
The PPVs we have reported are at study level i.e. across studies. Each study reflects practice 
of multiple clinicians, who may vary considerably. A PPV does not indicate whether the 
referral to TIA clinic was appropriate for the patient, and/or whether a more appropriate 
action should have been taken.  
 
Interpretation in the light of existing literature: Whilst we were unable to determine 
measures of sensitivity and specificity, positive predictive values are a key statistic used in 
predictive risk modelling and the planning of prevention services. (19)   
Our study found that PPVs for TIA are quite high (as compared with other conditions with 
fast-track referral) (20-22) but the key message is that TIA is an uncertain diagnosis. The use 
of PPVs as statistics for planning TIA services has been contested (23), as patients with 
transient symptoms that are not due to TIA have been recognized as a similarly morbid 
population to true TIA. (24-26) Clinical need is therefore not limited to confirmed TIAs but to 
the broader populace with transient symptoms. The dual findings of our review - relatively 
high but variable predictive values and a predominance of cardiovascular pathologies - 
suggests that active risk factor management, including early initiation of antiplatelet agents 
is still appropriate to mitigate early recurrent stroke risk after initial suspicion of TIA. (27) 
 
Implications for research and practice: Our study shows that TIA specialist services need to 
handle a broad range of diagnoses, not just TIA. Many of the most common alternate 
diagnoses could benefit from appropriate specialty input and the challenge for 
commissioners of services is how best to deliver comprehensive care for patients who 
present with transient neurological symptoms. While the TIA clinic is well placed to manage 
the hyper-acute risk of recurrent stroke it may not be the optimal configuration in terms of 
specialist assessment for the range of neurological, cardiological and psychiatric conditions 
which also require ongoing care. 
 
Funding: This study was unfunded, but RK previously carried out a literature review on this 
topic as part of a University of Birmingham medical school studentship. DL is supported by 
the NIHR Oxford Biomedical Research Centre and the NIHR Oxford Diagnostic Evidence 
Cooperative. This study represents independent research funded by the NIHR Oxford 
Biomedical Research Centre and the NIHR Oxford Diagnostic Cooperative. The views are 
those of the authors and not necessarily those of the NIHR, the NHS or the Department of 
Health. 
Ethical approval: Not applicable 
Competing interests: The authors state that there are none. 
Acknowledgments: We wish to thank Professor Willie Hamilton for commenting on the 
study design. 
 
 
 
 
 
 
  
References 
 
1. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: 
a scientific statement for healthcare professionals from the American Heart Association/American 
Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on 
Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the 
Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology 
affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40(6):2276-
93. 
2. Gibson LM, Whiteley W. The differential diagnosis of suspected stroke: A systematic review. 
Journal of the Royal College of Physicians of Edinburgh. 2013;43(2):114-8. 
3.  Gibbs RG, Newson R, Lawrenson R, et al. Diagnosis and initial management of stroke and 
transient ischemic attack across UK health regions from 1992 to 1996: experience of a national 
primary care database. Stroke. 2001;32(5):1085-90 
4. Murray S, Bashir K, Lees KR, et al. Epidemiological aspects of referral to TIA clinics in 
Glasgow. Scottish Medical Journal. 2007;52(1):4-8. 
5. Bos MJ, van Rijn ME, Witteman JM, et al. INcidence and prognosis of transient neurological 
attacks. JAMA. 2007;298(24):2877-85. 
6. Mant JR, McManus R, Fletcher K, et al. What is the Optimum Model of Service Delivery for 
Transient Ischaemic Attack? Report for the National Coordinating Centre for NHS Service Delivery 
and Organization R&D. Universities of Birmingham, Oxford and Newcastle.Available from: 
http://www.netscc.ac.uk/hsdr/files/project/SDO_FR_08-1504-112_V01.pdf. 2008. 
7.           Bachmann LM, Coray R, Estermann P., ter Riet, G. Identifying diagnostic studies in MEDLINE: 
reducing the number needed to read. JAMIA. 2002;9:653–658. 
8. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality 
assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-36. 
9. Ferro JM, Falcao I, Rodrigues G, et al. Diagnosis of transient ischemic attack by the 
nonneurologist: A validation study. Stroke. 1996;27(12):2225-9. 
10. Cameron AC, Dawson J, Quinn TJ, et al. Long-term outcome following attendance at a 
transient ischemic attack clinic. International Journal of Stroke. 2011;6(4):306-11. 
11. Kleinig T, Hall L, Jannes J, Dowie G. There's (almost) no such thing as a TIA; high rates of TIA-
mimics and minor stroke in a tertiary MRI-and emergency referral-based TIA service. International 
Journal of Stroke. 2013;8:48-. 
12. Martin PJ, Young G, Enevoldson TP, Humphrey PRD. Overdiagnosis of TIA and minor stroke: 
Experience at a regional neurovascular clinic. QJM - Monthly Journal of the Association of Physicians. 
1997;90(12):759-63. 
13. Lavallee PC, Meseguer E, Abboud H, et al. A transient ischaemic attack clinic with round-the-
clock access (SOS-TIA): feasibility and effects. Lancet Neurology. 2007;6(11):953-60. 
14. Fonseca AC, Canhao P. Classification of transient neurological attacks in a TIA clinic. 
Cerebrovascular Diseases. 2009;27:71-2. 
15. Magin P, Lasserson D, Parsons M, et al. Referral and triage of patients with transient 
ischemic attacks to an acute access clinic: Risk stratification in an Australian setting. International 
Journal of Stroke. 2013;8:81-9. 
16. Lasserson DS, Mant D, Hobbs FD, Rothwell PM. Validation of a TIA recognition tool in 
primary and secondary care: implications for generalizability. International Journal of Stroke. 
2015;10(5):692-6. 
17. Fallon C, Noone I, Ryan J, et al. Assessment and management of transient ischaemic attack--
the role of the TIA clinic. Irish Journal of Medical Science. 2006;175(3):24-7. 
18. Banerjee S, Natarajan I, Biram R, et al. FAST-TIA: A prospective evaluation of a nurse-led 
anterior circulation TIA clinic. Postgraduate Medical Journal. 2009;85(1010):637-42. 
19. Nuffield Trust. Choosing a predictive risk model: a guide for commissioners in England. 
November 2011. 
20. Hjertholm P, Moth G, Ingeman ML, Vedsted P. Predictive values of GPs' suspicion of serious 
disease: a population-based follow-up study. Br J Gen Pract. 2014;64(623):e346-53. 
21. Astin M, Griffin T, Neal RD, et al. The diagnostic value of symptoms for colorectal cancer in 
primary care: a systematic review. Br J Gen Pract. 2011;61(586):e231-43. 
22. Shapley M, Mansell G, Jordan JL, Jordan KP. Positive predictive values of >/=5% in primary 
care for cancer: systematic review. Br J Gen Pract. 2010;60(578):e366-77. 
23. Giles MF, Rothwell PM. Substantial underestimation of the need for outpatient services for 
TIA and minor stroke. Age Ageing. 2007;36(6):676-80. 
24. Bos MJ, van Rijn MJ, Witteman JC, et al. Incidence and prognosis of transient neurological 
attacks. JAMA. 2007;298(24):2877-85. 
25. Tuna M.A, Li L., Tornada A, et al. The 12-year risk of Stroke and Coronary Events after focal 
and non-focal transient neurological attacks: a population-based study. The 2nd European Stroke 
Organisation Conference 2016. 2016;Volume: 1 issue: 1_suppl, page(s): 613-780. 
26. Tuna MA, Tornada A, Li L, et al. Short and long-term risk of stroke after a specialist diagnosis 
of TIA/minor stroke mimic: A population-based study. International Journal of Stroke. 2015;10:66. 
27. Rothwell PM, Algra A, Chen Z, et al. Effects of aspirin on risk and severity of early recurrent 
stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised 
trials. Lancet. 2016. 
28. Bradley D, Cronin S, Kinsella JA, et al. Frequent inaccuracies in ABCD2 scoring in non-stroke 
specialists' referrals to a daily Rapid Access Stroke Prevention service. Journal of the neurological 
sciences. 2013;332(1-2):30-4. 
29. Dawson J, Cameron AC, Walters MR, et al. Neurological morbidity and mortality following 
attendance at a transient ischaemic attack clinic. Stroke. 2011;42 (3):e250. 
30. Dutta D. Diagnosis of TIA (DOT) score - design and validation of a new clinical diagnostic tool 
for transient ischaemic attack. BMC Neurology. 2016;16 (1) (no pagination)(20). 
31. Dutta D, Bowen E, Foy C. Four-year follow-up of transient ischemic attacks, strokes, and 
mimics: a retrospective transient ischemic attack clinic cohort study. Stroke; a journal of cerebral 
circulation. 2015;46(5):1227-32. 
32. Fallon C, Noone I, Ryan J, et al. Assessment and management of transient ischaemic attact - 
The role of the TIA clinic. Irish Journal of Medical Science. 2006;175(3):24-7. 
33. Karunaratne PM, Norris CA, Syme PD. Analysis of six months' referrals to a "one-stop" 
neurovascular clinic in a district general hospital: implications for purchasers of a stroke service. 
Health bulletin. 1999;57(1):17-28. 
34. Lasserson DS, Mant D, Hobbs FDR, Rothwell PM. Validation of a TIA recognition tool in 
primary and secondary care: Implications for generalizability. International Journal of Stroke. 
2015;10(5):692-6. 
35. Lee W, Frayne J. Transient ischaemic attack clinic: An evaluation of diagnoses and clinical 
decision making. Journal of Clinical Neuroscience. 2015;22(4):645-8. 
36. Magin P, Lasserson D, Parsons M, et al. Referral and triage of patients with transient 
ischemic attacks to an acute access clinic: Risk stratification in an Australian setting. International 
Journal of Stroke. 2013;8(100 A):81-9. 
37. Palomeras Soler E, Fossas Felip P, Cano Orgaz AT, et al. Rapid assessment of transient 
ischaemic attack in a hospital with no on-call neurologist. [Spanish]. Neurologia. 2015;30(6):325-50. 
38. Sheehan OC, Merwick A, Kelly LA, et al. Diagnostic usefulness of the ABCD2 score to 
distinguish transient ischemic attack and minor ischemic stroke from noncerebrovascular events: the 
North Dublin TIA Study. Stroke. 2009;40(11):3449-54. 
39. Walker J, Isherwood J, Eveson D, Naylor AR. Triaging TIA/minor stroke patients using the 
ABCD2 score does not predict those with significant carotid disease. European Journal of Vascular & 
Endovascular Surgery. 2012;43(5):495-8. 
40. Kee Y, Negansan C, Mahmood S, Lawrence E. Fast +ve vs Fast -ve: An analysis of patients 
presenting to TIA clinic. International Journal of Stroke. 2015;10:55. 
41. Lebus C, Prabhakaran M, Mitchell J, et al. The ABCD2 score as a predictor of prognosis but 
also accurate diagnosis of TIA in a large teaching hospital service. Cerebrovascular Diseases. 
2012;33:524-5. 
42. Martinovic O, Baht H, Balogun I, et al. An appointment based tia service is unable to 
accommodate all high risk patients < 24hrs. Cerebrovascular Diseases. 2010;29:238. 
43. Trolan C, McCormick M. Prioritisation of referrals to a district general neurovascular clinic: 
Role of ABCD2. Irish Journal of Medical Science. 2013;182:S281. 
44. Yu CT, Tam YM, Tang SK, et al. A prospective evaluation of diagnostic yield of transient 
ischemic attack (TIA) in a nurse-led TIA clinic in Hong Kong. Cerebrovascular Diseases. 2013;36:29. 
45. Fonseca M, Canhao P. Early vascular risk after TIA: Comparison between a weekly and daily 
TIA clinic. Journal of Neurology. 2011;258:S34. 
46. Freitas J, Damasio J, Magalhaes R, et al. Strokes ABCD2 score in the distinction between 
vascular and non-vascular transient neurologic attack. Cerebrovascular Diseases. 2010;29:238-9. 
47. Hall C, Oczkowski W. UTILITY of the ABCD and ABCD2 scores in identifying true TIA events in 
the emergency department. Canadian Journal of Emergency Medicine. 2010;12 (3):232. 
48. Rosales CF, Choy LGY. Three year TIA clinic audit from a UK district general hospital. 
Cerebrovascular Diseases. 2015;39:173. 
 
 
Figure 1: Study Flow
Unique records identified through 
database searching 
(n = 3,924) 
Additional records identified 
through reference screening 
(n = 3) 
Records included on basis of title and 
abstract 
(n=128) 
Records excluded 
(n =109) 
84 did not present sufficient details to determine 
PPVs 
11 non-original data  
1 non-original data containing new information 
on alternate diagnoses 
2 reference standard ambiguous and possibly 
different from review 
11 conference abstracts with sufficient 
information to calculate PPVs [included in 
sensitivity analysis] 
 
Full-text articles included in 
review  
(n =19)  
Figure 2: Positive predictive values of first-contact healthcare diagnosis in TIA and stroke 
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Martin, 1997
Murray, 2000
Palomeras Soler, 2015
Sheehan, 2009
47.16 (41.22, 53.17)
48.51 (38.45, 58.67)
31.58 (28.80, 34.47)
30.48 (26.56, 34.61)
47.86 (38.54, 57.29)
19.23 (9.63, 32.53)
12.90 (3.63, 29.83)
56.55 (51.87, 61.14)
24.22 (17.09, 32.58)
40.74 (36.46, 45.13)
72.53 (69.77, 75.17)
15.85 (8.72, 25.58)
22.83 (15.86, 31.12)
44.23 (34.40, 54.30)
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Table A2: Extracted data (stratified by referral route) for clinician accuracy1 
Study  
 
[country: region] 
Type Referral 
source  
Mean age 
(sd) 
TIAs TIA or 
Stroke 
Diagnosis 
unknown 
Total, N PPV for 
reference 
dx of TIA 
 
PPV for 
reference 
dx of TIA 
& stroke 
Banerjee et al, 2009(18) 
[England UK: London] 
Prospective 
cohort†  
GP & ED  68 (13.5) 133 213 2 
unknown,  
15 
unavailab
le 
282 47.2 75.5 
Bradley et al, 2013(28) 
[Ireland: Dublin] 
Prospective 
cohort 
GP & ED 60 (14.3) 49 56 None  101 48.5 55.4 
Cameron et al, 2011(10) 
[Scotland UK: Glasgow] 
Prospective 
cohort 
GP & ED 65 (13.6) - 1890 None  3533 - 53.5 
Dawson et al, 2009(29) 
[Scotland UK: Glasgow] 
Prospective 
cohort 
GP & ED  65 (12.8) - 2358 None  3467 - 68.3 
Dutta et al, 2016 (30) 
[England UK: Gloucester] 
Prospective 
cohort – DOT 
validation cohort  
GP & ED  71 (14.0) 160 236 None  525 30.5 45.0 
Dutta et al, 2015(31) 
[England UK: Gloucester] 
Prospective 
cohort 
GP & ED 72‡  (IQR: 
60-80) 
337 529 None  1067 31.6 49.6 
Fallon et al, 2006(32) [Ireland: 
Dublin] 
Prospective 
cohort 
ED 
(primarily) & 
other – not 
specified 
75.5 (-) 56 72 18 117 47.9 61.5 
Ferro et al, 1996(9) 
[Portugal: central and 
southern] 
Prospective 
cohort 
GP  - 10 36 None  52 19.2 69.2 
                                                          
1 Where there is more than one data entry for a single study this reflects that the study provided sufficient information to calculate PPVs by different referral sources. 
† PPVs only reported for suspected TIAs which were seen at an anterior circulation TIA clinic. 
‡ median not mean reported 
 
Study  
 
[country: region] 
Type Referral 
source  
Mean age 
(sd) 
TIAs TIA or 
Stroke 
Diagnosis 
unknown 
Total, N PPV for 
reference 
dx of TIA 
 
PPV for 
reference 
dx of TIA 
& stroke 
Ferro et al, 1996(9) 
[Portugal: central and 
southern] 
Prospective 
cohort 
ED - 4 18 None 31 12.9 58.1 
Fonseca et al, 2009(14) 
[Portugal: Lisbon] 
Prospective 
cohort 
GP & ED 65 (-) 259 
definite 
TIA 
- 109 cases 
recorded 
as 
“possible
” TIA 
458 -56.6 - 
Karunaratne et al, 1999(33) 
[Scotland, UK, Scotland: 
Borders] 
Prospective 
cohort 
GP & ED 67 (14) 31 64 7 non-TIA  
with no 
clear 
diagnosis 
128 24.2 50.0 
Lasserson et al, 2013(34) 
[England UK: Oxford] 
 
Prospective 
cohort 
GP 73 (12.8) 209 - None  513 40.7 - 
Lavalee et al, 2007(13) 
[France: Paris] 
Prospective 
cohort 
GP & ED  No 
overall - 
median 
ages 
reported 
by final 
diagnosis 
alone  
643 
definite 
TIA 
701 144 cases 
recorded 
as 
“possible 
TIA” 
1085 72.5 77.9 
Lee et al, 2015(35) 
[Australia: Melbourne] 
Prospective 
cohort  
GP & ED 67 (16.9) 13 18 4 non-TIA 
with no 
clear 
diagnosis 
82 15.9 22.0 
Study  
 
[country: region] 
Type Referral 
source  
Mean age 
(sd) 
TIAs TIA or 
Stroke 
Diagnosis 
unknown 
Total, N PPV for 
reference 
dx of TIA 
 
PPV for 
reference 
dx of TIA 
& stroke 
Magin et al, 2013(36) 
[Australia: Hunter New 
England] 
Prospective 
cohort 
GP 65 (15)  29 50 13 
unclassifi
ed 
127 22.8 39.4 
Magin et al, 2013(36) 
[Australia: Hunter New 
England] 
Prospective 
cohort 
ED 65 (15)  46 66 9 
unclassifi
ed 
104 44.2 63.5 
Martin et al, 1997(12) 
[England, UK: Liverpool] 
Prospective 
cohort 
GP & ED 62‡ (IQR: 
23-94) 
200 - Unclear 332 60.2 - 
Murray et al, 2007(4) 
[Scotland, UK: Glasgow] 
Retrospective 
cohort 
GP & ED No 
overall. 
Age 
bands. 
217 283 None  811 26.8 34.9 
Palomeras Soler et al, 
2015(37) 
[Spain: Barcelona] 
Prospective 
cohort  
GP & ED - 282 310 None  411 68.6 75.4 
Sheehan et al, 2009(38) 
[Ireland: Dublin] 
 
Prospective 
cohort 
GP & ED 69 (13) 292 337 None  257 49.2 56.7 
Walker et al, 2012(39) 
[England, UK: Leicester] 
Prospective 
cohort  
GP & ED - - 1273 None  2452 - 51.9 
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Figure A5: PPV of first-contact healthcare diagnosis in TIA (sensitivity analysis including 
original data contained in conference abstracts).  
 
* Conference abstracts not included in main analysis. 
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